The National Institute of Allergies and Infectious Diseases is leading COVID-19 clinical trial efforts through a large-scale network, called the COVID-19 Prevention Network (CoVPN). Dr. Jim Kublin, the executive director of operations program for CoVPN, shares more about this government-funded clinical trials network for COVID-19, the importance of diversity in research, and how tech is rapidly advancing medical discoveries.
HealthCast
Season 2
Episode 1
23m listen
Ensuring Participant Diversity in COVID-19 Vaccine Trials
Share
Modern technology has the power to overcome clinical trial participation challenges.
-
Dr. Jim Kublin Executive Director of Operation Programs CoVPN
Related Content
-
How Holistic IT Strategies Drive Mission Outcomes
Former GSA associate CIO Erika Dinnie shares lessons on holistic modernization and offers practical guidance for federal employees exploring private sector opportunities.
5m watch -
Marne Innovation Center Empowers Soldiers to Solve Battlefield Challenges
The Army’s Marne Innovation Center is transforming battlefield efficiency by sourcing real-time problems and solutions directly.
12m listen -
From Fed to Founder: Joe Scheidler on People, Policy, Innovation
Joe Scheidler outlined lessons from his White House and State Department tenure that helped drive his startup success.
7m watch -
IHS Modernizes Native Health Care with PATH EHR
IHS CIO Mitchell Thornbrugh shares how PATH EHR is transforming Native health care through data liberation, scalable systems and community-driven innovation.
18m listen
